Lexaria Bioscience Corp. (NASDAQ:LEXXW) Sees Large Increase in Short Interest

Lexaria Bioscience Corp. (NASDAQ:LEXXW) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling 1,906 shares, a growth of 30.0% from the December 15th total of 1,466 shares. Based on an average daily trading volume, of 40,357 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 40,357 shares, the days-to-cover ratio is currently 0.0 days.

Lexaria Bioscience Stock Performance

LEXXW traded down $0.00 on Monday, hitting $0.00. The company had a trading volume of 283,190 shares, compared to its average volume of 55,749. The stock has a fifty day simple moving average of $0.02 and a 200-day simple moving average of $0.07. Lexaria Bioscience has a 52-week low of $0.00 and a 52-week high of $0.80.

About Lexaria Bioscience

Lexaria Bioscience Corp. is a pharmaceutical company specializing in the development of novel drug delivery platforms for orally administered, lipid-soluble molecules. The company’s core technology, DehydraTECH®, is designed to enhance the absorption, onset and bioavailability of compounds such as cannabinoids, nicotine and certain pharmaceutical actives. By embedding these compounds into food and beverage products or nutraceuticals, Lexaria aims to offer a more efficient alternative to traditional delivery methods.

Established in 2012 and headquartered in Kelowna, British Columbia, Lexaria has conducted preclinical and clinical studies to validate its DehydraTECH® platform.